Investors focusing too much attention on large technology stocks like Tesla and Facebook have perhaps overlooked smaller upcoming technology companies with huge upside potential.
A company that we have discovered is APTY(APT Systems, Inc.). APTY is an up and coming tech firm out of San Francisco, CA. APTY has been receiving increased attention from the street. If you are discovering APTY for the first time, start your own due diligence right away. APTY has been receiving significantly increased attention from the street. APTY has a newly released app for stock research, and APTY also recently launched SNAPT games a gaming app subsidiary of APTY.
Technology along with Cannabis stocks present interesting and at times very lucrative opportunities.
These Tech and Cannabis companies are making waves: APT Systems Inc. (OTCPINK:APTY), 22nd Century Group, Inc. (XXII), CV Sciences, Inc. (OTCQB: CVSI), Aphria Inc. (OTCQB:APHQF), Aurora Cannabis Inc. (OTCQX: ACBFF)
APT Systems Inc. (OTCPINK: APTY)
Market Cap: $1.42M, current share price: $.004
The company reported news today that its newly released app KenCharts was steadily progressing. APTY is a company that specializes in the creation of innovative stock research tools, an equities trading platform called Intuitrader and delivering visualization solutions for the financial markets. APTY has dedicated charting indicators and apps under the brand KenCharts that we intend to expand into tracking cryptocurrencies. APT Systems recently launched its subsidiary SNAPT Games to further facilitate long term goals. APTY has acquired and are developing games for handheld devices with a view to using some of the gaming technology inside the trading platforms.
CV Sciences, Inc. (CVSI)
Market Cap: $469.63M Share Price: $5.18
CV Sciences (CVSI) has received more positive attention after it announced that it had appointed Joseph Maroon, MD, FACS to its Board of Directors. The Nevada-based company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
22nd Century Group, Inc. (XXII)
Market Cap: $341.074M, current share price: $2.760
The plant biotechnology company XXII focuses on tobacco harm reduction and hemp/cannabis research. The FDA announced big plans in 2017 to limit nicotine in cigarettes to minimally or non-addictive levels which caused further research published in early 2018 by The National Academies of Sciences, Engineering, and Medicine (NASEM) evaluating the available scientific evidence addressing the short- and long-term health effects related to the use of electronic nicotine delivery systems (ENDS). James E. Swauger, Sr. VP of Sciences and Regulatory Affairs for XXII believes that the Company’s Very Low Nicotine tobacco technology demonstrates that the FDA’s plan to dramatically reduce nicotine in cigarettes is technologically feasible.
Aphria Inc. (OTCQB: APHQF)
Market Cap: $1.74B, current share price: $7.68
Aphria Inc., is one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
Aurora Cannabis Inc. (OTCQX: ACBFF)
Market Cap: $3B, current share price: $5.18
Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in a leading extraction technology company, Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber Inc. for an ownership stake exceeding 50.0%.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and twelve thousand dollars total by Regal Consulting, LLC, for APTY. APTY and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.
For Full Legal Disclaimer Click Here.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States